Lee Nathan M, Deriy Lev, Petersen Timothy R, Shah Vallabh O, Hutchens Michael P, Gerstein Neal S
Department of Anesthesiology and Critical Care Medicine, University of New Mexico School of Medicine, Albuquerque, NM.
Department of Internal Medicine, Division of Nephrology, University of New Mexico School of Medicine, Albuquerque, NM.
J Cardiothorac Vasc Anesth. 2019 Feb;33(2):348-356. doi: 10.1053/j.jvca.2018.07.042. Epub 2018 Aug 1.
Administration of excess chloride in 0.9% normal saline (NS) decreases renal perfusion and glomerular filtration rate, thereby increasing the risk for acute kidney injury (AKI). In this study, the effect of NS versus Isolyte use during cardiac surgery on urinary levels of tissue inhibitor of metalloproteinase 2 and insulin-like growth factor-binding protein 7 [TIMP-2] × [IGFBP7] and postoperative risk of AKI were examined.
Prospective, randomized, and single-blinded trial.
Single university medical center.
Thirty patients over 18 years without chronic renal insufficiency or recent AKI undergoing elective cardiac surgery.
Subjects were randomized to receive either NS or Isolyte during the intraoperative period.
The primary outcome was the change in urinary levels of [TIMP2] × [IGFBP7] from before surgery to 24 hours postoperatively. Secondary outcomes included serum creatinine pre- and postoperatively at 24 and 48 hours, serum chloride pre- and postoperatively at 24 and 48 hours, need for dialysis prior to discharge, and arterial pH measured 24 hours postoperatively. Sixteen patients received NS and 14 patients received Isolyte. Three patients developed AKI within the first 3 postoperative days, all in the NS group. The authors found increases in [TIMP-2] × [IGFBP7] in both groups. However, the difference in this increase between study arms was not significant (p = 0.92; -0.097 to 0.107).
The authors observed no change in urinary [TIMP-] × [IGFBP7] levels in patients receiving NS versus Isolyte during cardiac surgery. Future larger studies in patients at higher risk for AKI are recommended to evaluate the impact of high- versus lower-chloride solutions on the risk of postoperative AKI after cardiac surgery.
输注含0.9%生理盐水(NS)的过量氯化物会降低肾灌注和肾小球滤过率,从而增加急性肾损伤(AKI)的风险。在本研究中,探讨了心脏手术期间使用NS与使用平衡液对金属蛋白酶组织抑制因子2和胰岛素样生长因子结合蛋白7的尿水平[组织金属蛋白酶抑制因子2]×[胰岛素样生长因子结合蛋白7]以及术后AKI风险的影响。
前瞻性、随机、单盲试验。
单一大学医学中心。
30名18岁以上、无慢性肾功能不全或近期AKI且接受择期心脏手术的患者。
受试者在手术期间随机接受NS或平衡液。
主要结局是术前至术后24小时尿中[组织金属蛋白酶抑制因子2]×[胰岛素样生长因子结合蛋白7]水平的变化。次要结局包括术后24小时和48小时的术前和术后血清肌酐、术后24小时和48小时的术前和术后血清氯化物、出院前是否需要透析以及术后24小时测量的动脉pH值。16名患者接受NS,14名患者接受平衡液。3名患者在术后第1个3天内发生AKI,均在NS组。作者发现两组中[组织金属蛋白酶抑制因子2]×[胰岛素样生长因子结合蛋白7]均升高。然而,研究组间这种升高的差异不显著(p = 0.92;-0.097至0.107)。
作者观察到心脏手术期间接受NS与接受平衡液的患者尿中[组织金属蛋白酶抑制因子2]×[胰岛素样生长因子结合蛋白7]水平无变化。建议未来对AKI风险较高的患者进行更大规模的研究,以评估高氯溶液与低氯溶液对心脏手术后术后AKI风险的影响。